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CASE REPORT
A Sporadic Case of Mal de Meleda Caused by Gene 
Mutation in SLURP-1 in Korea
Young Jae Oh, M.D., Ha Eun Lee, M.D., Joo Yeon Ko, M.D., Young Suck Ro, M.D., Hee Joon Yu, 
M.D.
Department of Dermatology, Hanyang University College of Medicine, Seoul, Korea
Mal de Meleda (MDM), also known as keratoderma 
palmoplantaris transgrediens, is a rare inherited form of 
palmoplantar keratoderma. It is characterized by erythema 
and hyperkeratosis of the palms and soles, extending to the 
dorsal aspects of the hands and feet. A 15-year-old Korean 
female presented with sharply demarcated hyperkeratotic 
plaques on the palms and soles, which extended to the dorsal 
surfaces of the hands and feet, in a “glove-and-socks” 
distribution. The histopathologic study showed marked 
hyperkeratosis, acanthosis, and normogranulosis, without 
epidermolysis. Her genetic study detected compound 
heterozygous mutation in exon 3 of the ARS gene encoding 
SLURP-1. Family history did not reveal any other affected 
members and no consanguineous relationship was found. In 
view of these findings, we diagnosed this case as the first 
reported sporadic case of MDM in Korea, the farthest 
location from the endemic island of Meleda. (Ann Dermatol 
23(3) 396∼399, 2011)
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INTRODUCTION
Mal de Meleda (MDM) is an uncommon, autosomal 
recessive form of palmoplantar keratoderma (PPK), with 
most cases reported in descendants of the inhabitants of the 
island of Meleda (now Mljet), in Croatia
1,2.
  Recently, a 
number of sporadic cases have also been reported in more 
widespread areas, such as the Middle East, Northern Africa, 
Turkey, Sweden and Taiwan
3. We herein present a sporadic 
case of MDM in a 15-year-old Korean female who had 
several clinical obligatory features and mutations in the ARS 
gene, encoding SLURP-1. Interestingly, Korea is not only 
geographically the farthermost area from the endemic area, 
but is also traditionally a homogeneous society. 
CASE REPORT
A 15-year-old female presented with diffuse palmoplantar 
thickening that had been present from birth. In the 
beginning, the lesions were limited to only her fingertips. 
However, with age, they progressively spread to the 
dorsal surfaces of the hands and feet. Since the age of ten, 
old, waxy ivory-yellow, palmoplantar hyperkeratotic pla-
ques, with well-demarcated margins, accompanied with 
nail change, have been present. On cutaneous exami-
nation, we observed extensive diffuse hyperkeratosis of 
the palms and soles, which extended to the dorsal 
surfaces of the hands and feet (Fig. 1). She had knuckle 
pads on several interphalangeal joints and on both 
elbows. Conical tapering of the fingers and nail changes 
included thickening of the nail and hypercurvature. She 
also had a thin tongue, with several furrows at the distal 
portions of the tongue. The palmoplantar skin revealed an 
unpleasant smell, and maceration with hyperhidrosis, 
especially during the summer months. Teeth, hair, and 
general physical examination were unremarkable. None A Sporadic Case of Mal de Meleda
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Fig. 1. (A~D) Well-demarcated hyper-
keratotic plaque, involving the palms
and soles. Note the hyperkeratosis of
the dorsa of the hands and feet. Con-
stricting band-like lesions around digits,
particularly the 2nd to 4th fingers in 
both hands, are shown.
Fig. 2. Pedigree of the patient.
of the family members were affected and no consan-
guineous relationship was found (Fig. 2). The potassium 
hydroxide (KOH) mounts from the hyperkeratotic lesions 
of the palm, sole, dorsa of hands and feet, fingernail, and 
toenail, were all positive. Other laboratory work up was 
normal. Histopathologic findings of the sole, as well as the 
dorsa of the hand and foot, showed marked hyper-
keratosis, acanthosis, and normogranulosis, without epi-
dermolysis (Fig. 3A). PAS-positive spores and hyphae were 
present in the stratum corneum (Fig. 3B). Her genetic 
study detected mutations in SLURP-1 (Table 1). From 
these findings, she was diagnosed as MDM. She was 
topically treated with a mixture of 50% salicylic acid and 
steroid ointments, and systemically with oral antifungal 
and antibiotic agents. After combined treatments, the 
hyperkeratotic plaques showed some improvement, in-
cluding reduction in thickness, especially in the erythe-
matous dorsal borders, and the malodorous smell dis-
appeared. 
DISCUSSION
The PPKs are a heterogenous group of disorders, charac-
terized by thickening of the skin of the palms and soles
4. 
They can initially be categorized, based on whether they 
are inherited or acquired. Then they can be further sub-
divided, based on clinical patterns. MDM, one of the 
autosomal recessive forms of PPK, is clinically charac-
terized by a well-demarcated erythema and hyperkeratosis 
of the palms and soles, that usually occurs soon after birth. 
The hyperkeratosis spreads slowly to the dorsal aspects of 
the hands and feet, which is referred to as transgradiens. 
Many patients will experience bothersome pain due to 
fissures. Hyperhidrosis with maceration is also charac-
teristic of MDM, and is often accompanied by malodor. In 
addition, patients may develop keratotic plaques over 
joints, nail abnormalities, brachydactyly, pseudoanihum 
and perioral erythema
5.
Our case showed the following compatible clinical features: 
“glove-and-socks” distribution of the keratoderma, with a 
sharp demarcation that appeared after birth, and pro-
gressively extended to the dorsa of the hands and feet; nail 
changes; conical tapering of the fingertips; and malo-
dorous palmoplantar hyperhidrosis. 
In 2001, mutations in the gene encoding SLURP-1 located 
on the chromosome 8q24.3 were found as the cause of YJ Oh, et al
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Fig. 3. Marked hyperkeratosis and acanthosis on the middle of sole (H&E, scanning view) (A), PAS-positive spores and hyphae in 
the stratum corneum (×200) (B).
Table 1. Mutations in the gene encoding SLURP-1 in our patients
Exon Nucleotide Codon Base change Amino acid change Designation Variation type
3 256 86 G>A Gly>Arg p.Gly86Arg Missense mutation
3 286 96 C>T Arg>Stop p.Arg96X Nonsense mutation
MDM
6. It is currently identified that SLURP-1 is an epi-
dermal secreted neuromodulator that influences both 
epidermal homeostasis and inhibition of tumor necrosis 
factor-alpha release by macrophage, during the wound 
healing process. Such roles would explain the hyper-
proliferative and inflammatory clinical characteristics of 
the MDM
7. Herein, we analyzed our patient for mutations 
in SLURP-1. Mutations analysis revealed compound hete-
rozygous mutation in exon 3 of the ARS gene. A hete-
rozygous G to A transition at neucleotide 256 resulted in a 
missense mutation in SLURP-1 at the amino acid position 
86. This missense mutation has been previously reported 
in patients from Palestine and Taiwan
1,2. She also 
exhibited a heterozygous C to T transition at nucleotide 
286, leading to conversion of the arginine risidue to a stop 
codon at amino acid 96. This nonsense mutation has been 
described in patients from Turkey and Croatia
1. 
Although MDM is not a life-threatening disease, its 
chronic disfigured hyperkeratotic lesions with malodor 
can lead to impaired social activity and occupational 
hazard. Treatment is extremely important at this point, 
even though it is not yet possible to completely heal this 
genetic disorder. Therapeutic options include urea con-
taining moisturizers or keratolytics, such as salicylic acid. 
The aromatic retinoids etretinate and acitretin usually 
produce improvement of PPK
8. Of importance, however, 
is that early and long-term use of retinoid associates with 
several well-known adverse effects. In addition, antibiotic 
and antifungal therapy is helpful, if needed
9. Although it is 
not a pathognomonic finding, many patients with MDM 
have an increased risk of either bacterial or fungal 
infection that may increase the skin thickening and may 
result in an unpleasant smell. Our patient has taken 
antibiotic and antifungal treatments, resulting in not only 
disappearance of malodor, but also thinning of the dorsal 
hyperkeratotic plaques. Because the various treatments 
may offer symptomatic relief, it is important to be aware 
that continuous treatment is necessary in the management 
of this life-long disease. 
MDM was originally described in patients from the island 
of Meleda in Croatia. However, recently, MDM has been 
observed in more widespread countries beyond the Mljet 
island, and several sporadic cases have been reported
3. 
Our case has an important meaning, in that it has 
occurred in Korea, currently the farthest country from the 
Mljet Island and with no connection in history. In addi-
tion, we emphasize that a comprehensive long-term, 
follow-up plan, particularly if supported by effective se-A Sporadic Case of Mal de Meleda
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condary infection management strategies, can be sur-
prisingly helpful.
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